AMLI (The Association of Medical Laboratory Immunologists), Pittsburgh PA, Corgenix promotes their expanded line of Auto Immune tests.
At the 2016 AACC Clinical Lab Expo August 2-4, Philadelphia PA, Corgenix and ORGENTEC company combined to exhibit their unique brand of products. ORGENTEC, a global specialty diagnostic company, highlighting its broad menu of more than 350 diagnostic tests including autoimmune, cardiovascular, infectious diseases and organ function assays. The Alegria® Analyzer is trusted in more than 1,000 placements around the world to improve lab accuracy and productivity while increasing flexibility in rare-disease testing, even for small labs. CORGENIX, a unique brand of quality and highlighting their autoimmune and cardiovascular offerings, including the AspirinWorks® test, the world’s only urine test for measuring thromboxane metabolites to determine aspirin effect. CORGENIX is also recognized as a superior partner in the industry for its contract R&D and contract manufacturing services and would welcome inquiries about its capabilities.
Dynex Technologies, Inc. (Chantilly VA) was founded in 1952, and has been a leading innovator in microplate analysis, pipettors, dispensers and dilutors for over fifty years. Today, Dynex designs and manufactures a full range of automated laboratory instruments and associated consumables that enable scientists and clinicians to make breakthrough discoveries, earlier, more-accurate diagnoses – innovations to improve health outcomes and enhance life. From fully automated ELISA instruments and the latest in analysis and control software, Dynex designs products to meet the rigorous demands of the most challenging applications. More information is available at www.dynextechnologies.com
Corgenix distributes several Dynex instruments in the US, including the DSX® Four-Plate Automated ELISA Processing System and the DS2® Two-Plate Automated ELISA Processing System.
Miami, Fl. Baptist Heatlh South Florida presents the 14th Annual Cardiovascular Disease Prevention Annual International Symposium and Miami Cardiac & Vascular Institute Cardiovascular Summit. Corgenix highlights their AspirinWorks® test, the world’s only urine test for measuring thromboxane metabolites to determine aspirin effect.
Publication in Reviews in Cardiovascular Medicine, Neath S-X et al. “The Current and Future Landscape of Urinary Thromboxane Testing to Evaluate Atherothrombotic Risk”. 2014, 15:2; 119-130. “….testing UTxB2 levels is an appropriate first step for identifying individuals at increased risk for downstream atherothrombotic events associated with cardiovascular disease.”
DENVER — June 3, 2015 —We are pleased to announce that ORGENTEC Diagnostika has finalized its acquisition of Corgenix Inc.
As a result, the Corgenix product range has transferred to ORGENTEC now holding the exclusive worldwide distribution rights. Effective July 1st, please direct orders and inquiries for Corgenix products to ORGENTEC who will be happy to handle your inquiries (or refer you to the appointed local distributor, if applicable). Be assured that we will do our best to keep supply seamless. ORGENTEC and Corgenix will work hard to earn your trust and loyalty.
If you have any questions, please contact us. Your ORGENTEC and Corgenix International Commercial Team